Streetbeat News

Stock Prices

HBI

HanesBrands has projected its Q3 2023 adjusted EPS to be between $0.07 and $0.13, which is lower than the estimated $0.2.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:05 am

BHR

CMCT

LAMR

MPW

NHI

The article lists the top 5 oversold real estate stocks, which are considered undervalued and present buying opportunities. The stocks are Medical Properties Trust, Inc. (MPW), Creative Media & Community Trust Corporation (CMCT), Braemar Hotels & Resorts Inc. (BHR), National Health Investors, Inc. (NHI), and Lamar Advertising Company (LAMR). All these stocks have an RSI value below 30, indicating they are oversold.

Portfolio Pulse from Lisa Levin

August 10, 2023 | 11:05 am

HBI

HanesBrands has projected its Q3 2023 net sales to be between $1.52 billion and $1.57 billion, which is lower than the estimated $1.68 billion.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:05 am

HBI

HanesBrands has projected its FY23 adjusted EPS to be between $0.16 and $0.30, which is lower than the estimated $0.31.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:04 am

OCX

OncoCyte (NASDAQ:OCX) reported Q2 losses from cont ops of $(1.03) per share, a significant increase from $(0.24) per share last year. However, the company's quarterly sales of $463.00 thousand beat the analyst consensus estimate of $360.00 thousand by 28.61 percent, despite being a 77.60 percent decrease from $2.07 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:04 am

HBI

HanesBrands has projected its FY23 net sales to be between $5.8 billion and $5.9 billion, which is lower than the estimated $6.05 billion.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:04 am

WKME

WalkMe has projected its Q3 revenue to be between $66M-$68M, which is lower than the street estimate of $69.15M. The company also forecasts its FY23 revenue to be between $266M-$270M, again lower than the estimated $271.73M.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:02 am

ASAN

CVBF

VAC

VTGN

Insiders at Vistagen Therapeutics, CVB Financial, Safehold, and Asana have made notable purchases of their companies' stocks. Vistagen Therapeutics' 10% owner Commodore Capital LP acquired 775,756 shares for around $17.96 million. CVB Financial's Director George A. Borba Jr bought 257,704 shares for around $4.99 million. Safehold's Chairman and CEO Jay Sugarman bought 65,420 shares for around $1.4 million. Asana's President, CEO and Chair Dustin Moskovitz bought 160,000 shares for around $3.45 million.

Portfolio Pulse from Lisa Levin

August 10, 2023 | 10:59 am

DDS

Dillard's has reported a 3% decrease in comparable store sales for Q2.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 10:59 am

BN

Brookfield (NYSE:BN) reported Q2 earnings of $0.75 per share, missing the analyst consensus estimate of $0.88 by 14.77%. The company also reported quarterly sales of $23.67 billion, missing the analyst consensus estimate of $30.51 billion by 22.43%. However, both earnings and sales saw a slight increase compared to the same period last year.

Portfolio Pulse from bharat@benzinga.com

August 10, 2023 | 10:58 am